Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-25-003088
Filing Date
2025-05-12
Accepted
2025-05-12 16:31:17
Documents
68
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q bysi20250331_10q.htm   iXBRL 10-Q 1146003
2 EXHIBIT 31.1 ex_812522.htm EX-31.1 12209
3 EXHIBIT 32.1 ex_812523.htm EX-32.1 4497
  Complete submission text file 0001171843-25-003088.txt   6137986

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA bysi-20250331.xsd EX-101.SCH 55871
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bysi-20250331_def.xml EX-101.DEF 367219
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE bysi-20250331_lab.xml EX-101.LAB 302132
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bysi-20250331_pre.xml EX-101.PRE 396956
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bysi-20250331_cal.xml EX-101.CAL 63437
71 EXTRACTED XBRL INSTANCE DOCUMENT bysi20250331_10q_htm.xml XML 911611
Mailing Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE, WEST SIDE, 4TH FLOOR SUITE 410 FLORHAM PARK NJ 07932 646-528-4184
BeyondSpring Inc. (Filer) CIK: 0001677940 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38024 | Film No.: 25935379
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)